Figures
Abstract
Background
PQBP1 is a causative gene for X-linked mental retardation (MR) whose patients frequently show lean body. C. elegans has a strictly conserved homologue gene of PQBP1, T21D12.3.
Methodology and Principal Findings
We generated Venus-transgenic and T21D12.3-mutant nematodes to analyze developmental expression patterns and in vivo functions of the nematode PQBP1 homologue protein (pqbp-1.1). During development, pqbp-1.1 is expressed from cell proliferation stage to larva stage. In larva, intestinal cells show the highest expression of pqbp-1.1, while it decreases in adult worms. The mutants of pqbp-1.1 show a decrease of the lipid content in intestinal cells. Especially, incorporation of fatty acid into triglyceride is impaired. ShRNA-mediated repression of PQBP1 also leads to reduction of lipid content in mammalian primary white adipocytes.
Citation: Takahashi K, Yoshina S, Masashi M, Ito W, Inoue T, Shiwaku H, et al. (2009) Nematode Homologue of PQBP1, a Mental Retardation Causative Gene, Is Involved in Lipid Metabolism. PLoS ONE 4(1): e4104. https://doi.org/10.1371/journal.pone.0004104
Editor: Sotirios Koutsopoulos, Massachusetts Institute of Technology, United States of America
Received: August 14, 2008; Accepted: December 3, 2008; Published: January 1, 2009
Copyright: © 2009 Takahashi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants to H.O. from Japan Science Technology Agency (PRESTO, JST, Japan) and from Ministry of Education, Culture, Sports, Science and Technology of Japan (16390249, 16650076, 18390254, 18650097, Research on Pathomechanisms of Brain Disorders: 17025017, 18023014, 20023011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
PQBP1 was identified as a binding protein to the polyglutamine (polyQ) tract of the causative gene products of a major group of neurodegeneration, polyglutamine diseases [1]. PQBP1 includes two protein interaction domains: WW domain (WWD) through which PQBP1 interacts with RNA polymerase II and NpwBP [2], [3] and C-terminal domain (CTD) through which it interacts with a splicing factor, U5-15kD [4], [5]. Subsequently, PQBP1 was identified as a causative gene for a group of mental retardation including Renpenning syndrome, Golabi-Ito-Hall and the Sutherland-Haan syndromes as well as non-symptomatic X-linked mental retardation with no anomaly [6]–[8]. The frequency of these PQBP1-linked disorders is relatively high [9]. Among various associating symptoms, one of the most frequent symptoms in these patients is lean body, which is found in 87% of the patients [10].
In this study, we investigated expression patterns of nematode homologue of PQBP1 (pqbp-1.1) during development, and generated mutants of T21D12.3. We found that pqbp-1.1 is expressed in intestinal cells storing lipid in nematodes and that the mutant of T21D12.3 shows reduction of lipid storage in intestinal cells although intestinal cells did not reduce in their number. Furthermore, we found shRNA-mediated knocking down of PQBP1 leads to reduction of lipid storage in mouse primary white adipocytes. These results suggest that PQBP1 is involved in lipid metabolism beyond species and that dysfunction of lipid metabolism might be a cause of lean body in human PQBP1 mutations.
Results
PQBP1 homologue is expressed in intestinal cells
C. elegans possesses a homologue gene of PQBP1, T21D12.3, which encodes a protein (pqbp-1.1) containing both of the essential protein interacting domains, WWD and CTD [11]. Amino acid identities between human and nematode PQBP1 are 35% in the whole molecule, 52% in WWD and 55% in CTD. To analyze expression patterns of T21D12.3, the PQBP1 homologue in C. elegans, we constructed a reporter plasmid expressing a fluorescent fusion protein of pqbp-1.1 and Venus, a variant of yellow fluorescent protein with fast and efficient maturation for visualization [12] under the control of T21D12.3 enhancer/promoter according to the method described previously [13]. Endogenously, T21D12.3 and T21D12.4 (pat-6) are regulated as an operon (Fig. 1). Therefore, we constructed a plasmid that contains 6.7 kb genome DNA from the 2.7 kb upstream of the neighboring gene (pat-6) to the 3′ end of T21D12.3 (Fig. 1). Thereafter, Venus cDNA was subcloned into exon 4 of T21D12.3 to express a nematode PQBP1-Venus fusion protein (pqbp-1.1-Venus).
T21D12.3 and T21D12.4 (pat-6) are transcriptionally regulated as an operon. Therefore, 6.7 kb genome DNA from the transcriptional initiation site to the neighboring gene to pat-6 was subcloned into pGEMT-T plasmid. By injecting the plasmid into germ line of adult worm, we obtained transgenic nematodes in which the Venus cDNA was subcloned into exon 4 to express a PQBP1-Venus fusion protein under the control of endogenous enhancer/promoter.
By injecting the reporter plasmid, we obtained F2 transgenic worms as described in Materials and Methods. The fluorescence signals of the pqbp-1.1-Venus fusion protein indicated that pqbp-1.1 was expressed from 24-cells stage to Larva stage 4 (L4) (Fig. 2, 3). From 24 cells- to gastrulation-stage, pqbp-1.1-Venus was expressed ubiquitously (Fig. 2). At L1 stage, neural cells in the head ganglion express the fusion protein (Fig. 3A). From late L1 stage, intestinal cells expressed pqbp-1.1-Venus strongly and the high expression continued to L4 stage. The peak of expression was observed at L3 stage. Pharyngeal cells show an almost similar pattern of expression during development, while the peak seems to be at L4 stage (Fig. 3C). Higher magnification of the signals revealed that the fusion protein formed speckle-like intranuclear dots (or nuclear bodies) just like mammalian PQBP1 [2], [11] (Fig. 3B, 3C).
A) Expression was detected after 24-cell stage. Pqbp-1.1-Venus was expressed in all cells until gastrulation stage. The fluorescence negative area corresponds to gastrulation lumen. B) From comma stage, expression of pqbp-1.1-Venus focused to intestine.
A) At L1 stage, pqbp-1.1-Venus fusion protein is expressed in progenitor neurons in head ganglion. Expression in intestinal cells increases from L1 to late L1 stgae. At L2 stage, pharyngeal and intestinal cells show strong signals. Gonad does not express the fusion protein. B) At L3 stage, pharyngeal and intestinal cells keep a high expression level of pqbp-1.1. Especially, intestinal cells the highest expression level during the development. Somatic gonads also show high signals, and a higher magnification reveals nuclear dots of fusion protein, which is similar to the intranuclear localization of mammalian PQBP1 [11]. Arrowheads indicate intestinal cells. C) At L4 stage, a small number of pharyngeal and intestinal cells show strong signals of pqbp-1.1-Venus. The nuclear dots of the fusion protein are observed in intestinal cells (arrowheads) similarly to L3 stage. Somatic gonads also show weak signals.
After becoming adult worm, pqbp-1.1-Venus expression reduced rapidly in pharynx, while the expression continued in intestinal cells (Fig. 4).
Expression in the pharynx decreases. Intestinal cells keep a high expression level of pqbp-1.1-Venus in adult worms. Arrowheads indicate intestinal cells. Somatic gonads show no expression of pqbp-1.1-Venus. In the tail region, fluorescence was detected in several neurons (arrows).
PQBP1 expression in somatic gonads and head ganglions
During the development, somatic gonad cells expressed pqbp-1.1-Venus only from L3 to L4 stage (Fig. 3B, C), and adult gonads or fertilized eggs did not express pqbp-1.1-Venus (Fig. 4).
Pqbp-1.1 expression was also observed in head ganglion cells at L1 stage. The expression in such neural precursor cells is consistent with the developmental expression pattern of PQBP1 in mice [14]. Some neurons in the tail show weak expression of pqbp-1.1-Venus in adult worms (Fig. 4). However, after L1 stage, expression in neurons was relatively weak in comparison to that in intestinal cells or somatic gonad, and further analysis is needed to clarify the detail.
Depletion of PQBP1 homologue leads to reduction of lipid storage
Screening of the T21D12.3 mutants was performed as described previously [15]. Consequently, a mutant (tm3004) was obtained from the screening, which lacks a part of the T21D12.3 genome including the first methionine sequence (Fig. 5A). Because the expression of T21D12.3 was rather confined to intestinal cells (Fig. 3, 4) and because intestinal cells play critical roles in nutritional state of nematode [16], we investigated intestinal lipid storage of these mutants in this study.
A) T21D12.3 is the strictly conserved homologue of mammalian PQBP1 possessing WW domain and C-terminal domain. The genome maps show deleted regions in the genome of T21D12.3 and T07A9.1 mutants. B) T07A9.1 possesses a homology only to C-terminal domain of PQBP1 and does not possess WW domain. The genome maps show deleted regions in the genome of T07A9.1 mutants.
To take advantage of lucent body of C. elegans, lipid storage was investigated by culturing on Nile Red-including dishes. It is known that the in vivo staining with Nile Red does not affect growth, feeding or lifespan of C. elegans [17]. The Nile Red signals in intestinal cells were clearly lower in homozygous tm3004 than in wild type N2 (Fig. 6A, B) although the number of intestinal cells did not change (Fig. 6A).
A) Worms were stained by culturing from the L1 stage to adult stage on a Nile Red-containing plate. Control worms (N2) show strong stains in intestinal cells. In the T21D12.3 mutants, Nile Red stains intestinal cells weakly and the stain signals in body cavity outside of eggs seem higher than that of N2. Nile Red stains in the T07A9.1 mutants were not changed so remarkable. B) Nile Red staining signals in intestinal cells were analyzed quantitatively by collecting signals from 6 worms (25 µm2). Asterisks indicate p<0.001 in Student's t-test. Quantitative analysis showed a significant difference between N2 and T21D12.3 mutants but not between N2 and T07A9.1 mutants.
To confirm these semi-quantitative results regarding lipid contents, we investigated the uptake of exogenous radio-labeled fatty acid (16∶0) into various types of lipids (Fig. 7A, B) and the total content of triglyceride (Fig. 7C) in the homozygous tm3004 mutants. The tm3004 mutant shows a decrease in uptake of fatty acid specifically into triglyceride, while the uptake into other phospholipids was not affected. The total content of triglyceride was also decreased (Fig. 7C). These results supported that the T21D12.3 mutation caused reduction of triglyceride, and suggest that the reduction was induced by either impaired synthesis or enhanced degradation of triglyceride.
A) Uptake of exogenous radio-labeled fatty acid (16∶0) into various lipids in normal (N2), homozygous tm3004 mutant, and homozygous tm3045 mutant nematodes. TLC was exposed to for 10 hours. B) Quantitative analysis of the results in Fig. 7A. C) Triglyceride contents in nematodes.
Depletion of PQBP1 paralogue does not lead to reduction of lipid storage
In addition to T21D12.3, the genome of C. elegans encodes another paralogue, T07A9.1 (pqbp-1.2), possessing a low homology to PQBP1 but lacking WWD. Thus, we similarly screened and obtained a mutant of T07A9.1 (tm3045) lacking a part of the gene (Fig. 5B). However, the mutant nematodes did not show reduced signals in Oil Red staining (Fig. 6A), abnormal uptake of radio-labeled fatty acid (16∶0) into triglyceride (Fig. 7A, B) or reduction of triglyceride contents (Fig. 7C). Therefore, pqbp-1.1 but not pqbp-1.2 seems to be a proper orthologue of PQBP1 at least from the aspects of molecular structure and lipid metabolism.
PQBP1 is involved in lipid metabolism of mammalian white adipocytes
We finally tested whether findings in C. elegans were applicable to mammalian adipocytes. Reviewing our previous in situ hybridization data confirmed expression of PQBP1 in fat tissues [14]. Primary white adipocytes prepared from newborn mice were transfected during growth phase with a plasmid PQBP1-shRNA-ZsGreen, which express both mouse PQBP1-shRNA and ZsGreen. We also used non-silencing shRNA-ZsGreen transfected and non-transfected cells as controls.
PQBP1-shRNA actually reduced PQBP1 protein in western blots with anti-PQBP1 antibodies (Fig. 8A). We observed lipid granules were decreased in PQBP1-shRNA expressing fluorescence-positive cells (arrows) in comparison to fluorescence-negative cells (arrowheads) in the same plate. Both the sizes and Oil Red staining intensities of lipid droplets were significantly reduced (Fig. 8B). Non-silencing shRNA / ZsGreen-expressing cells also did not show any significant change (Fig. 8B). These results collectively support that mammalian PQBP1 also decrease the lipid content.
A) Western blot shows that PQBP1-shRNA-IRES-ZsGreen plasmid suppresses PQBP1 protein in primary mouse white adipocytes. Non-silencing shRNA (ns-ShRNA) was used as a control. The band intensities are corrected with GAPDH and standardized with non-transfected cells (NT). B) Primary white adipocytes were stained by Oil Red after transfection with PQBP1-shRNA-ZsGreen or non-silencing shRNA-ZsGreen plasmid. Non-transfected cells (arrowheads) possess large lipid droplets while PQBP1-shRNA-transfected cells (green) show small granules (arrows). Non-silencing shRNA-transfection did not affect the size of lipid granules (arrows in lower panels).
Discussion
Nematode PQBP1 homologue is involved in lipid metabolism
The method used in this study, which detects a marker fusion protein (PQBP1-Venus) expression under the control of the endogenous enhancer/promoter, definitely shows the endogenous expression pattern of PQBP1 in C. elegans. The expression pattern of nematode PQBP1 was actually unexpected, since we had expected to observe a neuron-dominant expression pattern. However it is not rare that a molecule is differentially used in different organisms even if it is highly conserved beyond species. Moreover, PQBP1 is highly conserved in Arabidopsis although the plant does not have the brain.
Our results clearly showed that nematode pqbp-1.1 is expressed in cells for lipid-storage (Fig. 1–4) and that pqbp-1.1 depletion links to abnormal lipid metabolism in nematode (Fig. 5, 6). Mammals possess fat cells to store lipid in the body, while nematode keep lipid in intestinal cells. However, although the cell types for lipid storage are different, compositions of lipid (such as saturated or unsaturated fatty acid, triglyceride) and metabolic pathways are fundamentally conserved beyond species. In addition, the knock down experiment with shRNA showed reduction of lipid storage in mammalian white adipocyte (Fig. 7). Therefore, the mutant nematodes generated in this study could be a hypothetical model for the lean body symptom of human patients linked to PQBP1 mutations. This model will be available for further analysis of the detailed molecular mechanisms underlying the lean body, and such studies might develop PQBP1 to a novel target molecule in human lipid metabolism.
Lipid metabolism in PQBP1 and polyQ pathologies
PQBP1 is known to interact with mutant Htt [18]. Meanwhile, mutant huntingtin (Htt), the causative gene product of Huntington's disease (HD), is known to downregulate peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α) [19]–[21], a co-activator of peroxisome proliferator-activated receptor (PPAR-γ) that is essential for transcription of a number of genes involved in glucose metabolism and β-oxidation of fatty acid [for review see 22]. Interestingly, in addition to binding to the promoter, PGC-1α participates in RNA elongation and splicing through binding to factors anchored onto C-terminal domain of RNA polymerase II [22]. The binding property of PGC-1α to RNA polymerase II and splicing proteins is homologous to that of PQBP1 [2], [4], suggesting a possible relationship between PQBP1 and PGC-1α. Therefore, it might be worth analyzing whether PQBP1 is involved in the same transcription protein complex with PGC-1α and how PQBP1 affects lipid metabolism mediated by PGC-1α in normal physiology and in HD pathology.
A hypothesis to account for the change of lipid granules would be that PQBP1 regulates expression of Fsp27/CIDE-C, which locates at lipid droplets and influences their size [23], like PPAR-γ regulates Fsp27 [24]. CIDE-A, another lipid droplet-associated protein controlling triglyceride deposition in white adipocytes [25] might be another target of transcriptional control by PQBP1. Though we have obtained preliminary data to support the hypothesis (data not shown), these issues would be the next project regarding the lipid metabolism function of PQBP1.
PQBP1 expression in neurons of C. elegans
In this study, we focused on the lipid metabolism, and have not analyzed neuronal functions of the nematode homologue of PQBP1. However, in mammals, PQBP1 definitely functions in neurons and/or progenitor cells, and the neuronal functions are essential for understanding MR symptoms found in PQBP1-mutated patients. Here, we found that pqbp-1.1 was expressed in head ganglion cells at L1 stage (Fig. 3A), which may correspond to neural progenitor cells in mammals. Although our preliminary observation showed no remarkable decline of locomotive activity, further analysis is needed for definite evaluation and it is essential for understanding T21D12.3 function in learning and memory functions in C. elegans. Meanwhile, analysis of PQBP1 functions in neurons are now undergoing in our laboratory with Drosophila mutants and mammalian neural stem cells. Drosophila mutants show a unique type of learning impairment (unpublished observation), which is different from the long-term memory disturbance observed in transgenic fly overexpressing human PQBP1 [26]. These experiments using various animal models will promote understanding of the whole scheme of PQBP1 diseases and might lead to certain insights into basic biology in the future.
Human patients with mutations of the PQBP1 gene show mental retardation and microcephaly as major symptoms. However, PQBP1 is expressed widely in multiple tissues of mammals. Therefore, if different animal models have different advantages for analyzing multiple molecular functions of a gene, we should better take the merit. We should employ appropriate animal models for appropriate functional analyses. In this study, we took advantage of the nematode model for analyzing the phenotype in lipid metabolism. We have already constructed conditional knock out mice and RNAi-mediated knock down mice as well as fly models for analyzing neuronal functions of PQBP1, which will be reported elsewhere.
The “lean body” is not a tiny symptom because the research on this symptom might link to cell metabolism and the related disorders. Although the phenotype we observed in this study might be a downstream consequence of essential molecular functions of PQBP1, still this work shows a novel finding to suggest a possible involvement of PQBP1 in the lipid metabolism.
Materials and Methods
Plasmid construction for transgenic C. elegans expressing venus under the control of T21D12.3 enhancer/promoter
An about 6.7 kb DNA fragment containing an operon of T21D12.2 (pat-6) and T21D12.3 gene was amplified from N2 genome DNA with primers 5′-GCCTATCAATATCAGGCACA and 5′-CTTCGTCCCACCTACATAAC (Fig. 1) with KOD plus (Toyobo). One Adenine wad added to the end of the amplified DNA fragment during reaction. The genome fragment was subcloned into pGEMT-T Easy vector (Promega) and the resultant plasmid (pGEMT-T-T21D12.3) was digested with Pml I (BioLabs) which is unique in the exon 4 of the T21D12.3 gene. Venus gene cDNA was amplified from pFX-Venus vector [13] with primers 5′-ATGATGATAAGCAATCACGTGGAATGGTGAGCAAGGGCG and 5′-TTTCAGCATTATTGCCACGTGTCTTGTACAGCTCGTCCATGC, then the fragment was subcloned into the Pml I site of pGEMT-T-T21D12.3 with recombinase in-Fusion kit (Clontech). The Venus Open Reading Frame was adjusted to that of T21D12.3 by inserting “GA” to 5′ and “T” to 3′ end of Venus cDNA, giving rise to the plasmid was named pGEMT-T-T21D12.3-Venus. The junctions between T21D12.3 and Venus were confirmed by sequencing with primers AGAAATTTCCACAACAAGAA and TCTGGACCCTGTGACGTCAT.
Generation of transgenic C. elegans
pGEMT-T-T21D12.3-Venus (20 µg/ml) and pFX-RXT-myo-2 (20 µg/ml), a marker of pharyngeal muscle to distinguish transgenic worms, were mixed and injected into the germ line of adult worm, according to the method by Mello et al. [27]. After 3 days, fluorescence-positive F1 worms were picked up, and transferred to a new dish. After additional culture for 3–4 days, fluorescence-positive F2 worms were selected and named tmEx1642.
Screening of mutant C. elegans of T21D12.3 and T07A9.1
The deletion mutations used in this work were isolated as previously described [15]. Primers used in nested PCR screening for detecting T21D12.3 (tm3004) are as follows; first round: 5′-CCGGCGGCGATACCCATTAA-3′, 5′-CCTAATCAAACGACACCGTC-3′, second round: 5′-GCGATACCCATTAAGTACGA-3′, 5′-GTCTGGCTCAACAACTATGG-3′. Primers for screening T07A9.1 (tm3045) are as follows; first round: 5′- TCGCAAGTCCCTCATCATAG-3′, 5′- CGAAATAACTGTGTGCGCCT-3′, second round: 5′- ACAGTGATGACGTCGTCTAG-3′, 5′- CTATTGCGATTGAGATGCTC-3′. Sequence analysis of the deleted regions was performed as previously described. These deletion alleles were outcrossed at least twice.
After screening of the mutants, we obtained a line for TD21D12.3 (tm3004) and another line for T07A9.1 (tm3045). Deleted regions in the genome of these mutants were determined by sequencing of the PCR fragments from their genomes. The primers for TD21D12.3 were 5′-CCGGCGGCGATACCCATTAA and 5′-CCTAATCAAACGACACCGTC. The primers for T07A9.1 were 5′-CTGTACATATCTCTCGGGCA and 5′-AGGTCGTGCGTTGAATGAGA.
Nile Red staining of intestinal cells and morphological observation
Nile Red (5H-benzo[a] phenoxazine-5-one, 9-doethylamino) was solved in acetone at 500 µg/ml and diluted to 2.5 µg/ml with phosphate-buffered saline. 3 ml of the solution was layered on a 35 mm NGM plate and dried at room temperature. Starved worms were cultured for 3 days before observation. Microscopic images were obtained by Olympus BX-50 and Olympus SenSys CCD camera. Fluorescence of Nile Red was observed with a Rhodamine filter (580 nm). Nile Red staining images were obtained at the same magnification (20×) and same exposure time (260 msec). Signal intensities in the images were quantified using Aquacosmos (HAMAMATSU). The arbitrary signals of intestinal cells were subtracted by those of body cavity to standardize the intensities. More than 100 cells were quantified in each type of nematode.
Lipid uptake and content analyses with nematodes
Incorporation of exogenous [1-14C] stearic acid into C. elegans was analyzed as described previously [28]. For triglyceride analysis, lipids of synchronized young adult worms were extracted by the method of Bligh and Dyer [29], and the triglyceride contents were measured using enzymatic kit (Triglyceride E-test, Wako Pure Chemical Ltd.) according to the manufacturer's protocol.
PQBP1-shRNA plasmid construction
The shRNA expression plasmids against mouse PQBP1 was derived from the RNAi-Ready pSIREN-RetroQ-ZsGreen (Clontech) shRNA expression vector. The double-stranded DNA oligonucleotides encoding shRNA against PQBP1 were composed of a sense strand, a 9-nucleotide hairpin loop, the complementary anti-sense strand, a poly(A) termination signal and an Xho I site. The sequence was derived from mouse PQBP1 specific siRNAs (Qiagen):GAGGAAGAGATTATTGCTGAA (SI01387120). The synthesized double strand oligonuclotides containing the sense and anti-sense siRNA sequences (5′-GGATCCGGAGGAAGAGATTATTGCTGAATTCAAGAGATTCAGCAATAATCTCTTCCTCCTTTTTTCTCGAGGAATTC-3′) were inserted into the BamH I and EcoR I sites of the shRNA expression vectors at the 5′- and 3′-ends, respectively. A control non-silencing shRNA (GGATCCGTGCGTTGCTAGTACCAACTTCAAGAGATTTTTTACGGCGTGAATTC) was synthesized and inserted into the shRNA expression vector.
Primary culture of white adipocytes and shRNA transfection
White adipocytic precursor cells were obtained from Primary Cell Co., Ltd (Hokkaido, Japan). The cells were grown in growth medium (Dulbecco's Modified Eagle Medium, 10% foetal bovine serum, 10unit/ml penicillin, 10 µg/ml streptomycin, 17 µM pantothenic acid, 33 µM (+)-biotin, 100 µM ascorbic acid, 1 µM octanoic acid, and 50 nM Triiodothyronine) at 37°C and 5% CO2 for 24 hours. The cells were transferred to 10 cm dish pre-coated with collagen at a density of 2×104cells/cm2 and incubated for 12 hours. Thereafter, the cells were transfected with PQBP1 shRNA-ZsGreen plasmid using Effecten (Qiagen) and incubated for 12 hours. Transfection with a non-sense shRNA plasmid and the mock treatment were performed in parallel. Subsequently, the medium was changed to Dulbecco's Modified Eagle Medium containing 10% fetal bovine serum, 10unit/ml penicillin, 10 µg/ml streptomycin, 17 µM pantothenic acid, 33 µM (+)-biotin, 100 µM ascorbic acid, 1 µM octanoic acid, 50 nM Triiodothyronine, 10 µg/ml Insulin, and 2.5 µM Dexamethasone for 48 hours to differentiate the cells to white adipocyte. Finally, the cells were kept for 7 days in maintenance medium (Dulbecco's Modified Eagle Medium, 10% fetal bovine serum, 10unit/ml penicillin, 10 µg/ml streptomycin, 17 µM pantothenic acid, 33 µM (+)-biotin, 100 µM ascorbic acid, 1 µM octanoic acid, 50 nM Triiodothyronine, and 10 µg/ml Insulin) before image acquisition.
Oil Red staining of white adipocytes
White adipocytes were fixed two times with 4% paraformaldehyde in phosphate buffer, pH 7.4, for 15 min and 10 min, washed with PBS, and treated with 60% isopropanol for 1 min. Next, the cells were incubated with Oil Red for 10 min at 37°C. After Oil Red staining, cells were treated with 60% isopropanol for 2 min and washed three times with PBS.
Author Contributions
Conceived and designed the experiments: HA SM HO. Performed the experiments: KT SY MM Wi TI SM. Analyzed the data: HS SM HO. Contributed reagents/materials/analysis tools: HO. Wrote the paper: HA SM HO.
References
- 1. Waragai M, Lammers CH, Takeuchi S, Imafuku I, Udagawa Y, et al. (1999) PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum Mol Genet 8: 977–987.
- 2. Okazawa H, Rich T, Chang A, Lin X, Waragai M, et al. (2002) Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron 34: 701–713.
- 3. Komuro A, Saeki M, Kato S (1999) Association of two nuclear proteins, Npw38 and NpwBP, via the interaction between the WW domain and a novel proline-rich motif containing glycine and arginine. J Biol Chem 274: 36513–36519.
- 4. Waragai M, Junn E, Kajikawa M, Takeuchi S, Kanazawa I, et al. (2000) PQBP-1/Npw38, a nuclear protein binding to the polyglutamine tract, interacts with U5-15kD/dim1p via the carboxyl-terminal domain. Biochem Biophys Res Commun 273: 592–595.
- 5. Zhang Y, Lindblom T, Chang A, Sudol M, Sluder AE, et al. (2000) Evidence that dim1 associates with proteins involved in pre-mRNA splicing, and delineation of residues essential for dim1 interactions with hnRNP F and Npw38/PQBP-1. Gene 257: 33–43.
- 6. Kalscheuer VM, Freude K, Musante L, Jensen LR, Yntema HG, et al. (2003) Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation. Nat Genet 35: 313–315.
- 7. Lenski C, Abidi F, Meindl A, Gibson A, Platzer M, et al. (2004) Novel truncating mutations in the polyglutamine tract binding protein 1 gene (PQBP1) cause Renpenning syndrome and X-linked mental retardation in another family with microcephaly. Am J Hum Genet 74: 777–780.
- 8. Kleefstra T, Franken CE, Arens YH, Ramakers GJ, Yntema HG, et al. (2004) Genotype-phenotype studies in three families with mutations in the polyglutamine-binding protein 1 gene (PQBP1). Clin Genet 66: 318–326.
- 9. de Brouwer AP, Yntema HG, Kleefstra T, Lugtenberg D, Oudakker AR, et al. (2007) Mutation frequencies of X-linked mental retardation genes in families from the EuroMRX consortium. Hum Mutat 28: 207–208.
- 10. Stevenson RE, Bennett CW, Abidi F, Kleefstra T, Porteous M, et al. (2005) Renpenning syndrome comes into focus. Am J Med Genet 134: 415–421.
- 11. Okazawa H, Sudol M, Rich T (2001) PQBP-1 (Np/PQ): a polyglutamine tract-binding and nuclear inclusion-forming protein. Brain Res Bull 56: 273–280.
- 12. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, et al. (2002) A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 20: 87–90.
- 13. Gengyo-Ando K, Yoshina S, Inoue H, Mitani S (2006) An efficient transgenic system by TA cloning vectors and RNAi for C. elegans. Biochem Biophys Res Commun 349: 1345–1350.
- 14. Qi Y, Hoshino M, Wada Y, Marubuchi S, Yoshimura N, et al. (2005) PQBP-1 is expressed predominantly in the central nervous system during development. Eur J Neurosci 22: 1277–1286.
- 15. Gengyo-Ando K, Mitani S (2000) Characterization of mutations induced by ethyl methanesulfonate, UV, and trimethylpsoralen in the nematode Caenorhabditis elegans. Biochem Biophys Res Commun 269: 64–69.
- 16.
Ashrafi K (2007) Obesity and the regulation of fat metabolism. WormBook. pp. 1–20.
- 17. Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, et al. (2003) Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421: 268–272.
- 18. Busch A, Engemann S, Lurz R, Okazawa H, Lehrach H, et al. (2003) Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease. J Biol Chem 278: 41452–41461.
- 19. Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, et al. (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127: 59–69.
- 20. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, et al. (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127: 397–408.
- 21. Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, et al. (2006) Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab 4: 349–362.
- 22. Puigserver P, Spiegelman BM (2003) Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24: 78–90.
- 23. Nishino N, Tamori Y, Tateya S, Kawaguchi T, Shibakusa T, et al. (2008) FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J Clin Invest. [Epub ahead of print].
- 24. Matsusue K, Kusakabe T, Noguchi T, Takiguchi S, Suzuki T, et al. (2008) Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab 7: 302–11.
- 25. Puri V, Ranjit S, Konda S, Nicoloro SM, Straubhaar J, et al. (2008) Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci U S A 105: 7833–7838.
- 26. Yoshimura N, Horiuchi D, Shibata M, Saitoe M, Qi ML, et al. (2006) Expression of human PQBP-1 in Drosophila impairs long-term memory and induces abnormal courtship. FEBS Lett 580: 2335–2340.
- 27. Mello CC, Kramer JM, Stinchcomb D, Ambros V (1991) Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J 10: 3959–3970.
- 28. Lee HC, Inoue T, Imae R, Kono N, Shirae S, et al. (2008) Caenorhabditis elegans mboa-7, a Member of the MBOAT Family, Is Required for Selective Incorporation of Polyunsaturated Fatty Acids into Phosphatidylinositol. Mol Biol Cell 19: 1174–84.
- 29. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911–7.